• Skip to primary navigation
  • Skip to main content
  • Skip to footer
  • English
    • Español (Spanish)
MotherToBaby

MotherToBaby

Medications and More during pregnancy and breastfeeding

Hide Search
Show Search
866.626.6847
  • About
    • Our Work
    • Our Team
    • Our Partners
  • Exposures
    • Pregnancy & Breastfeeding Exposures
    • Fact Sheets
    • Baby Blogs
    • Podcasts
  • Studies
    • Ongoing Studies
    • Pregnant Women
    • Join Now
    • Health Providers
    • Pharma Industry
    • Publications
  • Health Professionals
    • Patient Education and Provider Resources
    • Refer a Patient
    • Request Materials
    • Meetings
    • FAQs
    • OTIS Membership
  • Media
    • Press Releases
    • Media Requests
  • In Your Area
  • OTIS
    • About OTIS
    • OTIS Membership
    • Annual Meeting
    • Member Log-In
    • Donate
  • Contact

Oxymetazoline

November 1, 2019

This sheet talks about exposure to oxymetazoline pregnancy and while breastfeeding. This information should not take the place of medical care and advice from your healthcare provider.

What is oxymetazoline?

Oxymetazoline is a medication that is used in nasal sprays (sprayed into nostrils) and topical preparations (applied to skin). Oxymetazoline has been used to treat nasal congestion, eye inflammation, and skin redness. Oxymetazoline works by constricting blood vessels (makes the blood vessels smaller). Oxymetazoline can be found in prescription products and in many over the counter products. Some examples are: Afrin®, Dristan®, Nostrilla®, Rhofade®, and Vicks®.

I use oxymetazoline. Can it make it harder for me to get pregnant?

Studies have not been done in women to see if oxymetazoline could make it harder to get pregnant.

I just found out that I am pregnant. Should I stop taking oxymetazoline?

Talk with your healthcare providers before making any changes to this medication.

Does taking oxymetazoline increase the chance for miscarriage? 

Miscarriage can occur in any pregnancy. Studies have not been done to see if oxymetazoline increases the chance for a miscarriage.

Does taking oxymetazoline in the first trimester increase the chance of birth defects?

In every pregnancy, a woman starts out with a 3-5% chance of having a baby with a birth defect. This is called her background risk. A small number of studies on oxymetazoline use have not found that oxymetazoline increases the chance of birth defects.

Could taking oxymetazoline in the second or third trimester cause other pregnancy complications?

Oxymetazoline did not affect uterine blood flow in 12 pregnancies when the healthy mother was given a one-time nasal spray dose.

Does taking oxymetazoline in pregnancy cause long-term problems in behavior or learning for the baby?

This has not been studied with the use of oxymetazoline.

Can I breastfeed while taking oxymetazoline?

Oxymetazoline has not been well studied for use while breastfeeding. However, since this is not an oral medication (it is sprayed into nose or rubbed onto skin) it is thought that very little of the medication could reach breastmilk. Be sure to talk to your healthcare provider about all of your breastfeeding questions.

If a man takes oxymetazoline, could it affect his fertility (ability to get partner pregnant) or increase the chance of birth defects? 

This has not been studied. In general, exposures that fathers have are unlikely to increase risks to a pregnancy. For more information, please see the MotherToBaby fact sheet Paternal Exposures and Pregnancy at https://mothertobaby.org/fact-sheets/paternal-exposures-pregnancy/pdf/.

Selected References:

  • Aselton P, et al. 1985. First-trimester drug use and congenital disorders. Obstet Gynecol 65:451-455, 1985.
  • Baxi LV, et al. 1985. Fetal heart rate changes following maternal administration of a nasal decongestant. Am J Obstet Gynecol. 153:799-800.
  • Jick H, et al. 1981. First-trimester drug use and congenital disorders. JAMA 246:343-346.
  • Rayburn WF, et al. 1990. Uterine and fetal Doppler flow changes from a single dose of a long-acting intranasal decongestant. Obstet Gynecol. 76:180-2.
  • Yau W-P, et al. 2013. Use of decongestants during pregnancy and the risk of birth defects. Am J Epidemiol. 178(2):198-208.

View PDF Fact Sheet

Related Baby Blogs

  • Ho, Ho, Ho, Who Wouldn’t Go? Holiday Travel in the Time of COVID-19
  • Pregnant & the Flu Vaccine? Why It’s More Important Than Ever during the COVID-19 Pandemic
  • Birth Defects Prevention Month Series: Making Medication Decisions in Pregnancy Doesn’t Have to Be Lonely

Related Fact Sheets

  • Pseudoephedrine
  • Phenylephrine

Footer

           

Hot Links

  • Home
  • Exposures
  • Fact Sheets
  • Baby Blogs
  • Podcasts
  • Pregnancy Studies
  • Join a Study Now
  • Healthcare Professionals
  • Refer a Patient
  • Request Materials
  • News
  • Donate
  • Ask An Expert

Current Studies

  • Ankylosing Spondylitis
  • Asthma
  • Coronavirus (COVID-19)
  • Crohn’s Disease
  • Eczema (Moderate-to-Severe)/Atopic Dermatitis
  • Juvenile Idiopathic Arthritis
  • Multiple Sclerosis
  • Pertussis/Tdap vaccine (“Whopping Cough” vaccine)
  • Psoriasis
  • Psoriatic Arthritis
  • Rheumatoid Arthritis
  • Ulcerative Colitis

Contact

Exposure Information Service
866.626.6847

Pregnancy Studies
877.311.8972

Media Inquiries
619.368.3259
nchavez@mothertobaby.org

MotherToBaby, a service of the Organization of Teratology Information Specialists
OTIS Logo

OTIS National Office
5034A Thoroughbred Lane
Brentwood, TN 37027

Copyright © 2021 The Organization of Teratology Information Specialists

  • Accessibility
  • Privacy
  • Terms
  • Site Map
^